190
Views
2
CrossRef citations to date
0
Altmetric
Articles

Complications in skin grafts when continuing antithrombotic therapy prior to cutaneous surgery requiring skin grafting: an observational study

ORCID Icon, , &
Pages 352-357 | Received 20 Feb 2020, Accepted 05 Jun 2020, Published online: 21 Jun 2020

References

  • Adelborg K, Grove EL, Sundboll J, et al. Sixteen-year nationwide trends in antithrombotic drug use in Denmark and its correlation with landmark studies. Heart. 2016;102(23):1883–1889.
  • Isted A, Cooper L, Colville RJ. Bleeding on the cutting edge: a systematic review of anticoagulant and antiplatelet continuation in minor cutaneous surgery. J Plast Reconstr Aesthet Surg. 2018;71(4):455–467.
  • O’Neill JL, Taheri A, Solomon JA, et al. Postoperative hemorrhage risk after outpatient dermatologic surgery procedures. Dermatol Surg. 2014;40(1):74–76.
  • Harbottle M, Telfer M, Hunjan PS, et al. Bleeding complications in cutaneous surgery for patients on warfarin who have skin cancer of the head and neck. Br J Oral Maxillofac Surg. 2014;52(6):523–526.
  • Liu X, Lammers L, Nelemans PJ, et al. Preoperative management of antithrombotic medication in Mohs micrographic surgery. Acta Derm Venereol. 2015;95(7):845–847.
  • Cook-Norris RH, Michaels JD, Weaver AL, et al. Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation. J Am Acad Dermatol. 2011;65(3):584–591.
  • Alam M, Goldberg LH. Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy. Dermatol Surg. 2002;28(11):992–998; discussion 998.
  • Kimyai-Asadi A, Jih MH, Goldberg LH. Perioperative primary stroke: is aspirin cessation to blame? Dermatol Surg. 2004;30(12 Pt 2):1526–1528. discussion 1528–1529.
  • Heard LK, Shanahan C, Maggio KL. Complications with new oral anticoagulants dabigatran and rivaroxaban in cutaneous surgery. Dermatol Surg. 2017;43(4):597–599.
  • Kovich O, Otley CC. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol. 2003;48(2):233–237.
  • Koenen W, Kunte C, Hartmann D, et al. Prospective multicentre cohort study on 9154 surgical procedures to assess the risk of postoperative bleeding - a DESSI study. J Eur Acad Dermatol Venereol. 2017;31(4):724–731.
  • Otley CC. Continuation of medically necessary aspirin and warfarin during cutaneous surgery. Mayo Clin Proc. 2003;78(11):1392–1396.
  • Jarjis RD, Jorgensen L, Finnerup K, et al. Complications in skin grafts when continuing antithrombotic therapy prior to cutaneous surgery requiring skin grafting: a systematic review. J Plast Surg Hand Surg. 2015;49(3):129–134.
  • Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.
  • Dobbs E. SketchAndCalc. [Accessed 2004, 2019; Published 2011]. Available from: www.SketchAndCalc.com.
  • Nast A, Ernst H, Rosumeck S, et al. Risk of complications due to anticoagulation during dermatosurgical procedures: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2014;28(12):1603–1609.
  • Eichhorn W, Kluwe L, Heiland M, et al. Lack of evidence for increased risk of postoperative bleeding after cutaneous surgery in the head and neck in patients taking aspirin. Br J Oral Maxillofac Surg. 2014;52(6):527–529.
  • Reddy KS, Chittoria RK, Babu P, et al. Effectiveness of fibrin glue in adherence of skin graft. J Cutan Aesthet Surg. 2017;10(2):72–75.
  • Han HH, Jun D, Moon SH, et al. Fixation of split-thickness skin graft using fast-clotting fibrin glue containing undiluted high-concentration thrombin or sutures: a comparison study. Springerplus. 2016;5(1):1902.
  • Tan WXE, Lee JT, Kang GCW, et al. Reverse alphabetical grafting: an innovation to ensure successful split-thickness skin grafting. Plast Reconstr Surg Glob Open. 2019;7(7):e2317.
  • Palamaras I, Semkova K. Perioperative management of and recommendations for antithrombotic medications in dermatological surgery. Br J Dermatol. 2015;172(3):597–605.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.